This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Astom Corporation. Active years: 2015-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2026
Title: Minoru Kawashima: Innovator in Bipolar Membrane Technology
Introduction
Minoru Kawashima is a notable inventor based in Shunan, Japan. He has made significant contributions to the field of membrane technology, particularly through his innovative work on bipolar membranes. With a total of 2 patents to his name, Kawashima continues to push the boundaries of what is possible in this area.
Latest Patents
Kawashima's latest patents include a bipolar membrane and a process for producing the same. This bipolar membrane is characterized by the distribution of particles of a basic metal chloride at the interface between a cation-exchange membrane and an anion-exchange membrane. Another patent focuses on improving the adhesion between these two types of membranes without increasing the membrane voltage. This innovation features a bipolar membrane that comprises a cation-exchange membrane and an anion-exchange membrane joined together, with at least one of the ion exchange membranes containing a chlorinated polyolefin.
Career Highlights
Kawashima is currently associated with Astom Corporation, where he applies his expertise in membrane technology. His work has been instrumental in advancing the efficiency and effectiveness of bipolar membranes, which are crucial in various industrial applications.
Collaborations
Throughout his career, Kawashima has collaborated with notable colleagues such as Kazunori Nishio and Kazuo Mizuguchi. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Minoru Kawashima's contributions to bipolar membrane technology highlight his role as a leading inventor in this field. His innovative patents and collaborations continue to influence advancements in membrane applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile